Patent Docs: GW Pharmaceuticals Wins FDA Approval of First CBD Drug
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2022 Earnings Call Transcript
Teva makes first foray into medical cannabis sector, with new distribution deal | The Times of Israel
Innocan raises NIS 12.5m. to develop CBD-based COVID-19 treatment - The Jerusalem Post
Teva, Cipla, Lupin, Among Firms Sued Over Landmark Cannabidiol Drug :: Generics Bulletin
Teva Israel enters medical cannabis market with new partnership | Reuters
Jazz Pharmaceuticals Sues CBD Drug Competitors for Patent Infringement | Cannabis Equipment News
Yoav Zafrir - Quality Control technician II - Teva Pharmaceuticals | LinkedIn
Teva subsidiary inks distribution deal with Israeli medical marijuana product maker | Fierce Pharma
Teva makes first foray into medical cannabis sector, with new distribution deal | The Times of Israel
Rahul Lade - Senior Officer - Teva Pharmaceuticals | LinkedIn
CBD Line Uses NFC for Consumer Trust, Education | Healthcare Packaging
InnoCan Pharma CBD delivery approach holds potential to lower costs, broaden treatment options
Novartis blazes Big Pharma trail, striking deal with Canadian company to distribute medical marijuana products | Fierce Pharma
Teva Israel steps into the ring to begin distributing medical cannabis - The Jerusalem Post
Canndoc and Super-Pharm Sign Long-Term Partnership Agreement
The Week In Cannabis: Big Pharma Makes Moves, Diddy & Wahlberg Go After CBD, Medicine Man Continues M&A Spree
CBD outlook 2019: upbeat results for Epidiolex for TSC seizure treatment
Pharma Company Behind FDA-Approved CBD Drug Sues A Dozen Competitors Over Alleged Patent Infringement - Marijuana Moment
CBD Line Uses NFC for Consumer Trust, Education | Healthcare Packaging
GW Pharma's CBD Seizure Drug Epidiolex Approved In Europe As Adjunctive Therapy
EmpowerPharm Inc. Developing Prescription CBD Therapy for Treating Anxiety
Teva Pharmaceutical in medical cannabis deal with Cannbit-Tikun Olam | Seeking Alpha
